{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:41:30Z","timestamp":1781494890438,"version":"3.54.1"},"reference-count":29,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CTSC","award":["UL1 TR 002384"],"award-info":[{"award-number":["UL1 TR 002384"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>We investigated genetic counseling and testing rates for patients with gynecologic malignancy at a tertiary care center with a large minority population. Our retrospective cohort included newly diagnosed epithelial ovarian, fallopian tube, peritoneal, or endometrial cancer patients between January 2014 and June 2022. For endometrial cancer, 373 patients were identified. A total of 207 (55%) patients were screened using mismatch repair immunohistochemistry (MMR IHC). A total of 82 (40%) had MMR deficiencies on IHC. Of these, 63 (77%) received genetic counseling. A total of 62 (98%) underwent genetic testing, and ultimately, 7 (11%) were diagnosed with Lynch syndrome (LS). The overall rate of LS was 1.9%. MMR IHC testing increased steadily, reaching 100% in 2022. For ovarian cancer, 144 patients were identified. A total of 104 (72%) patients received genetic counseling, and 99 (95%) underwent genetic testing. Rates were not influenced by race, ethnicity, insurance type, or family history of cancer. They were significantly different by cancer stage (p &lt; 0.01). The proportion of patients who received genetic counseling increased from 47% in 2015 to 100% in 2022 (p &lt; 0.01). Most counseling was performed by a gynecologic oncologist (93%) as opposed to a genetic counselor (6.7%). Overall, 12 (8.3%) patients were BRCA+. High rates of counseling and testing were observed with few disparities.<\/jats:p>","DOI":"10.3390\/cancers16081598","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T03:57:07Z","timestamp":1713758227000},"page":"1598","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["No Racial Disparities Observed Using Point-of-Care Genetic Counseling and Testing for Endometrial and Ovarian Cancer in a Diverse Patient Population: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2813-2123","authenticated-orcid":false,"given":"Michael","family":"Kim","sequence":"first","affiliation":[{"name":"New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY 11215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Hayek","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, State University of New York Downstate Medical Center, Brooklyn, NY 11203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1601-0636","authenticated-orcid":false,"given":"Cheyenne","family":"Acker","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjile","family":"An","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilin","family":"Zhang","sequence":"additional","affiliation":[{"name":"New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY 11215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Gorelick","sequence":"additional","affiliation":[{"name":"New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY 11215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux J.","family":"Kanis","sequence":"additional","affiliation":[{"name":"New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY 11215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"ref_1","unstructured":"(2023, May 17). Genetic Testing for Gynecologic Cancer. Available online: https:\/\/www.sgo.org\/resources\/genetic-testing-for-gynecologic-cancer\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ygyno.2018.07.023","article-title":"Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer","volume":"151","author":"Lee","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1200\/JCO.19.00363","article-title":"Update on genetic testing in gynecologic cancer","volume":"37","author":"Domchek","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1002\/cncr.33625","article-title":"Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous\/nonmucinous epithelial ovarian cancer","volume":"127","author":"Kim","year":"2021","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.3802\/jgo.2023.34.e65","article-title":"Missing a chance to prevent: Disparities in completion of genetic evaluation in high-risk patients with endometrial cancer","volume":"34","author":"Holtzman","year":"2023","journal-title":"J. Gynecol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ygyno.2017.10.034","article-title":"Disparities in genetic assessment for women with ovarian cancer: Can we do better?","volume":"149","author":"Manrriquez","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ygyno.2019.01.024","article-title":"Disparities in gynecologic cancer genetics evaluation","volume":"153","author":"Hinchcliff","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Creeden, J.F., Nanavaty, N.S., Einloth, K.R., Gillman, C.E., Stanbery, L., Hamouda, D.M., Dworkin, L., and Nemunaitis, J. (2021). Homologous recombination proficiency in ovarian and breast cancer patients. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08863-9"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ygyno.2019.03.007","article-title":"Identifying disparities in germline and somatic testing for ovarian cancer","volume":"153","author":"Huang","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1136\/ijgc-2019-001168","article-title":"Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer","volume":"30","author":"Alimena","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12687-017-0347-z","article-title":"A comparison of cancer risk assessment and testing outcomes in patients from underserved vs tertiary care settings","volume":"9","author":"Rana","year":"2018","journal-title":"J. Community Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2021.05.011","article-title":"Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis","volume":"162","author":"Lin","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Harris, P.A., Taylor, R., Minor, B.L., Elliott, V., Fernandez, M., O\u2019Neal, L., McLeod, L., Delacqua, G., Delacqua, F., and Kirby, J. (2019). The REDCap consortium: Building an international community of software partners. J. Biomed. Inform., 95.","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/gim.2016.139","article-title":"Mastering genomic terminology","volume":"19","author":"Jarvik","year":"2017","journal-title":"Genet. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/jmg-2023-109370","article-title":"Ancestry, race and ethnicity: The role and relevance of language in clinical genetics practice","volume":"61","author":"Redman","year":"2024","journal-title":"J. Med. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11712","DOI":"10.1038\/s41598-021-91053-1","article-title":"Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer","volume":"11","author":"Huang","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41436-019-0536-8","article-title":"The proportion of endometrial cancers associated with Lynch syndrome: A systematic review of the literature and meta-analysis","volume":"21","author":"Ryan","year":"2019","journal-title":"Genet. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ygyno.2020.04.692","article-title":"Comparison of two Lynch screening strategies in endometrial cancer in a California health system","volume":"158","author":"Lentz","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2100409","DOI":"10.1200\/PO.21.00409","article-title":"Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current Practice","volume":"6","author":"Czekalski","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.4103\/ijc.IJC_458_19","article-title":"Mainstreaming genetic counseling for BRCA testing into oncology clinics-Indian perspective","volume":"56","author":"Verma","year":"2019","journal-title":"Indian. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1308\/rcsann.2024.0029","article-title":"Hereditary genetic testing and mainstreaming: A guide for surgeons","volume":"106","author":"Monaghan","year":"2024","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.annonc.2021.11.013","article-title":"European experts consensus: BRCA\/homologous recombination deficiency testing in first-line ovarian cancer","volume":"33","author":"Vergote","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ygyno.2020.05.001","article-title":"The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients","volume":"158","author":"Gleeson","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104098","DOI":"10.1016\/j.ejmg.2020.104098","article-title":"Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic","volume":"63","author":"Benusiglio","year":"2020","journal-title":"Eur. J. Med. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1200\/EDBK_350292","article-title":"Genetic Testing for All: Overcoming Disparities in Ovarian Cancer Genetic Testing","volume":"42","author":"Frey","year":"2022","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jgc4.1359","article-title":"Chatbots & artificial intelligence to scale genetic information delivery","volume":"30","author":"Nazareth","year":"2021","journal-title":"J. Genet. Couns."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/TACG.S245021","article-title":"Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers","volume":"14","author":"McAlarnen","year":"2021","journal-title":"Appl. Clin. Genet."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/8\/1598\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:32:01Z","timestamp":1760106721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/8\/1598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":29,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["cancers16081598"],"URL":"https:\/\/doi.org\/10.3390\/cancers16081598","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]}}}